Explore Our Network

3E Bioventures Capital is a life-sciences focused venture capital fund that invests in global health innovators. The firm targets Biotech (new drugs, new modalities, drug-discovery platforms) and TechBio (the intersection of biology and technology). 3E describes a science-driven, entrepreneur-friendly investment approach and partners with companies and research institutions to develop drugs or products addressing unmet medical needs. The firm’s motto is 3E: Expertise, Efficiency, Execution.

3M Ventures is the corporate venturing arm of 3M Company. It provides minority growth investments and incubates new businesses that align with 3M's strategic priorities. The team leverages 3M technology platforms, laboratories, manufacturing, commercial expertise and global customer networks to support partner companies.

501 Ventures is a life‑sciences focused firm that provides funding, strategic and scientific advisory services to accelerate development of patient therapies. The firm targets companies at critical growth and transition points and supports milestones across company development to streamline drug development and partnering/M&A activities.

5AM Ventures is a life-science focused investment firm founded in 2002 that funds and builds next-generation therapeutic and life-science companies. The firm emphasizes early-stage private therapeutics (with an emphasis on Series A) and operates a public equity strategy that invests in small- and mid-cap public and later-stage private biotech and life science companies. 5AM also runs an internal incubator (the 4:59 Initiative) to discover, incubate and fund breakthrough science and to establish proof-of-concept enabling Series A financings.

Aarin Capital is a proprietary venture fund that invests in technology-intensive businesses in life-sciences & healthcare, education, and other potentially large India-centric or India-first market opportunities. The firm aims to build profitable companies with sustainable value propositions by partnering with talented and ambitious management teams. Aarin Capital also invests in entrepreneurial fund managers to broaden access to the Indian start-up ecosystem.

Abacus Finance Group, LLC, based in New York City, is a leading provider of tailored credit solutions for sponsor-backed lower-middle market companies. With a focus on speed, flexibility, and certainty of close, Abacus is the go-to lender for private equity-backed transactions. The firm prides itself on its Total Partnership Approach™, combining deep industry knowledge with exceptional client service to ensure smooth and efficient buyout financing.

Abingworth is a transatlantic life-sciences investment firm that provides capital and development expertise to biotechnology and biopharma companies. The firm invests across the company lifecycle — from seed and early-stage through clinical development and public-market positions — and operates offices in London, Menlo Park/San Francisco and Boston. Abingworth is part of Carlyle. As of 29 February 2024 the firm reported investments in 185 life-science companies, including multiple M&A transactions and IPOs.

Accelerator Life Science Partners is a venture capital firm focused on investing in and nurturing early-stage biotechnology companies. The firm is dedicated to advancing life sciences breakthroughs into impactful health solutions. With a strategic approach to biotech investing, Accelerator LSP partners with research institutions and corporate VCs to support emerging biotechnology research opportunities, particularly in New York City and Seattle.

Accomplice is a venture firm and contemporary family office based in Boston. The firm describes itself as a high-conviction, concentrated, patient investor and participates in venture investing, operator-angel networks, blockchain initiatives, and anchor LP commitments to solo GP funds.

Acorn Pacific Ventures is a venture capital firm that continues a decades-long legacy of early-stage investments in Silicon Valley and the Asia Pacific region. The firm focuses on emerging technologies that integrate digital and real-world elements, proprietary technology, and cross-border expansion opportunities between Asia and the United States. Acorn Pacific Ventures leverages its extensive network and expertise to empower portfolio companies to excel beyond their domestic markets.

Adams Street Partners is a private markets investment firm that supports wealth managers and financial advisors by providing access to private markets knowledge and investment solutions. Their mission is to help clients grow and protect wealth through strategic private market investments. The firm offers a range of services including co-investments, growth equity, primary investments, private credit, secondary investments, and custom solutions, all tailored to meet the unique financial goals of their clients.

Advantage Capital is an impact-focused investment firm that provides tax-credit driven capital and structured financing to growth-ready small businesses, affordable housing developments and renewable energy projects, with an emphasis on directing capital to underserved communities while producing measurable impact and financial returns.

Global private equity firm focused on buyouts, growth and special-situation investments across five core sectors. Provides investment capital and hands-on portfolio support including operational transformation, digital scaling, M&A and leadership development through a global network of local investment teams and specialist advisors.

Agent Capital is a healthcare venture capital firm that invests in novel, differentiated therapeutics and treatments addressing unmet patient needs. The firm invests across all stages of development and works with scientists, entrepreneurs and co-investors to advance biotech programs toward clinical and commercial milestones and exits.

Aisling Capital is a healthcare-focused investment firm that invests in companies developing and commercializing pharmaceutical, biotechnology, medical device, diagnostics and services businesses. Since 2000 the firm has raised over $1.8 billion across four funds and takes an active approach—providing capital and strategic, operational and financial support to portfolio companies across private and public structures.

Aju IB Investment is a Korea-based venture capital and private equity firm that provides VC/PE funding, operates foreign investment funds and an accelerator business, and maintains a U.S. corporate presence (Solasta Ventures). The firm integrates ESG considerations into its investment process, has established an ESG committee and operating standards, and supports portfolio companies on international expansion and listing activities.

Global healthcare investment management firm focused on life-science innovation. Founded in 2013 with offices in New York and Hong Kong, the firm invests across private and public capital structures and combines scientific and clinical research evaluation with M&A and capital markets execution to support portfolio company development and cross-border commercialization. The firm is active in buyouts, take-private transactions and public listing advisory, including cross-border listings and relistings between the U.S., Hong Kong and mainland China.

Alta Partners is a healthcare-focused venture capital firm founded in 1996 with offices in San Francisco and Denver. The firm concentrates on early-stage investments in curative therapeutics and technology-enabled healthcare services and operates a family of NextGen funds to partner with entrepreneurs building novel biotherapeutics and healthcare delivery solutions. Alta highlights a focused portfolio approach and active operational support for portfolio companies.

Ampersand Capital Partners is a middle-market private equity firm (founded 1988) focused on growth-oriented investments in healthcare and life sciences. The firm invests via minority and majority equity positions and works with founders, management teams, and boards to drive organic growth, bolt-on M&A, and operational improvements. Ampersand manages approximately $3 billion in assets and builds companies across laboratory products, laboratory services, contract manufacturing, pharma services, and specialty products.

Amplitude Ventures is a leading venture capital firm focused on creating, building, and growing breakthrough healthcare companies. With a strong foundation in healthcare innovation, Amplitude Ventures aims to bring life-changing therapies to market, improving patient lives while delivering superior value to investors. The firm leverages its deep experience and strategic partnerships to support Canadian entrepreneurs in the healthcare sector, particularly in precision medicine, where they focus on enhancing diagnostics, developing targeted therapies, and integrating AI with biology.

Amzak Health is an evergreen venture fund focused on medtech and biotech. The firm invests in first-in-class and best-in-class technologies, supporting private and select public companies across their life cycle. Amzak emphasizes long-term partnerships with management teams, aiming to improve patient care and address unmet medical needs.